1. Home
  2. BBU vs FOLD Comparison

BBU vs FOLD Comparison

Compare BBU & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Business Partners L.P. Limited Partnership Units

BBU

Brookfield Business Partners L.P. Limited Partnership Units

HOLD

Current Price

$34.54

Market Cap

2.8B

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.30

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBU
FOLD
Founded
2016
2002
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
4.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
BBU
FOLD
Price
$34.54
$14.30
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$34.67
$27.56
AVG Volume (30 Days)
19.7K
20.1M
Earning Date
01-30-2026
02-18-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$27,790,000,000.00
$598,704,000.00
Revenue This Year
N/A
$21.49
Revenue Next Year
$5.85
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.28
52 Week Low
$18.63
$5.51
52 Week High
$37.38
$14.36

Technical Indicators

Market Signals
Indicator
BBU
FOLD
Relative Strength Index (RSI) 42.70 90.88
Support Level $35.14 $14.21
Resistance Level $37.38 $14.27
Average True Range (ATR) 1.14 0.10
MACD -0.16 0.03
Stochastic Oscillator 3.58 98.12

Price Performance

Historical Comparison
BBU
FOLD

About BBU Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP is a business services and industrials company. It focused on operating businesses that are either low-cost producers and benefit from high barriers to entry. The company's operating segment includes Business services; Infrastructure services; Industrials and Corporate and other. It generates maximum revenue from the Business Services segment. Geographically operates in USA, Europe, Australia, Brazil, Canada, UK, Mexico and Other, majority of revenue is from UK.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: